Mixing Benzodiazepines and Opioids

Benzodiazepines and opioids can together cause profound sedation, slowed breathing, and overdose. A coordinated medication review can address these risks while protecting needed treatment for pain, anxiety, and opioid use disorder.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Why Mixing Benzos and Opioids Needs a Coordinated Plan

Benzodiazepines and opioids are different classes of medicines that can both slow activity in the central nervous system, which includes the brain and spinal cord. Taking them together can increase profound sedation, slowed breathing, and overdose risk. A coordinated medication review helps address that interaction while considering why each medicine is needed.[1][2][3]

The right next step depends partly on whether the opioid treats pain or opioid use disorder. A review may lead to continuing treatment with additional support, reducing a medicine, or changing treatment. Stopping both medicines is not a universal goal, and abruptly stopping a regularly used benzodiazepine can cause dangerous withdrawal.[1][4][3]

Fast Facts About Mixing Benzodiazepines and Opioids
  • Benzodiazepines are not opioids. Their different actions can still combine to increase sedation and breathing problems.[2][4][3]
  • Current CDC pain-prescribing guidance calls for particular caution and an individual benefit–risk review, rather than a universal prohibition on concurrent prescribing.[3]
  • Benzodiazepine use alone should not lead to withholding or suspending buprenorphine or methadone treatment for opioid use disorder. The added interaction risk still needs medical management.[1][3]
  • Naloxone reverses opioid effects, not benzodiazepine effects. Suspected overdose requires immediate emergency help even when naloxone is available.[5]

Different Drug Classes – Are Benzos Opioids?

No. Benzodiazepines, often called benzos, are sedating medicines used for conditions such as anxiety, insomnia, and seizures, depending on the specific drug. Opioids include medicines used for pain and medicines used to treat opioid use disorder. The classes have different actions and treatment purposes, even though both can cause sedation.[2][4][3]

So, what is the difference between opioids and benzos? Benzodiazepines act through receptors for gamma-aminobutyric acid, or GABA, a chemical messenger that helps calm brain activity. Opioids act at opioid receptors. The benzos vs opioids distinction matters because a medicine’s intended benefit does not tell you whether it can interact dangerously with another prescription.[2][4][6]

Common Opioids and Benzodiazepines Examples

Examples of benzodiazepines include alprazolam (Xanax), lorazepam (Ativan), and diazepam (Valium). Opioid pain medicines include oxycodone and hydrocodone. These examples identify the classes, not interchangeable treatments. Each medicine has its own indications and prescribing considerations.[2][4]

Methadone and buprenorphine are also opioids. When prescribed for opioid use disorder, they have a different clinical purpose from an opioid prescription for pain. If your medication list contains any of these medicines, include what it treats when sharing the list with another prescriber or pharmacist. AddictionHelp.com’s benzodiazepine overview also explains the distinction between prescribed use, physical dependence, and addiction.[1][3][6]

Breathing Risk – How Does Combining Benzodiazepines and Opioids Cause Respiratory Depression?

Both classes can depress central nervous system activity, and benzodiazepines can increase opioid-related suppression of breathing. Respiratory depression means breathing becomes too slow or ineffective. The danger of mixing opioids and benzos includes profound sleepiness, impaired responsiveness, coma, and overdose. These risks do not establish a ranking of the combination as the deadliest in medicine.[2][3]

For example, mixing oxy and Xanax combines oxycodone, an opioid, with alprazolam, a benzodiazepine. Treating pain and anxiety as separate problems does not prevent the medicines’ sedating effects from overlapping. The practical next step is to have both prescriptions reviewed together, rather than evaluating each medicine in isolation.[1][2][3]

Profound sedation also matters because a person who becomes unresponsive cannot seek help. A household plan should therefore cover how someone else will recognize an emergency, call for help, and locate naloxone if opioids may be involved. Feeling awake at one point is not a reliable way to establish that a combination is safe.[2][4][5]

What the Overdose Evidence Can and Cannot Show

Research on prescription records has found an association between concurrent opioid and benzodiazepine prescriptions and overdose-related emergency care. That finding supports taking the interaction seriously, but it cannot predict an individual person’s outcome or prove that prescription overlap caused an overdose.[7]

A 2017 observational study examined prescription claims from privately insured adults ages 18–64 during 2001–2013. Overlapping prescriptions were associated with greater odds of an opioid-overdose emergency department visit or hospital admission than opioid prescriptions without benzodiazepine overlap. Overlap meant at least one day of prescription coverage, not confirmed simultaneous use. The outcome was emergency or hospital care, not fatal overdose. Differences among patients could also influence the association.[7]

Those historical claims do not describe today’s street-drug supply, and the study was not designed as an opioid use disorder treatment cohort. For example, its findings cannot tell someone receiving buprenorphine that stopping treatment would improve their health. That decision requires attention to the treatment’s benefits and the added interaction risk, which current guidance addresses separately.[1][3][7]

Why People Take Both and What Raises Concern

People may receive both medicines because pain, anxiety, sleep problems, and other conditions can overlap. Different prescribers may also be treating different needs. Having both prescriptions does not by itself establish addiction or show that either prescriber acted without a reason. It does create a need to review the complete treatment plan.[1][2][3]

For example, a new pain prescription may be added to an existing anxiety treatment. The useful question is whether the pain prescriber, anxiety prescriber, and pharmacist all have the same current medication list and understand the benefits each treatment provides. Include nonprescribed products as well. Their use deserves medical assessment without blame.[1][3]

All concurrent use warrants review. CDC guidance identifies greater concern with less predictable use, higher concurrent dosages, and alcohol or other central nervous system depressants. Stable prescribed use or a lower dose does not establish zero risk. The class warning includes diazepam and opioids as well as other benzodiazepine–opioid pairs. These factors are reasons for a clinical discussion, not a self-scoring system.[2][3]

Timing – How Long Should You Wait Between Taking Opioids and Benzodiazepines?

There is no universal waiting period that establishes personal safety. Benzodiazepines differ in how quickly they act and how long their effects last. The actual medicines, other substances, and individual health circumstances matter, so separating doses or feeling alert cannot be treated as a guarantee that the interaction is gone.[4][3]

Bring the exact medicine names and existing instructions to the prescriber or pharmacist and ask them to resolve any uncertainty about the combined plan. If two labels seem to conflict, that needs clarification for those prescriptions. An internet rule about waiting a certain number of hours cannot supply it.[1][4][3]

What FDA and CDC Guidance Says

The FDA warns about serious combined effects, while current CDC pain guidance calls for particular caution and an individualized benefit–risk review. Neither should be presented as a rule that everyone taking both medicines must abruptly stop them.[2][4][3]

In 2016, the FDA announced boxed warnings for the combined use of prescription opioid pain or cough medicines and benzodiazepines. The warnings describe extreme sleepiness, respiratory depression, coma, and death. In 2020, the FDA updated benzodiazepine boxed warnings to address abuse, misuse, addiction, physical dependence, and withdrawal, including the danger of abruptly stopping after regular use.[2][4]

The CDC’s 2022 guideline replaced its 2016 opioid pain-prescribing guidance. Recommendation 11 calls for particular caution with concurrent opioid pain medicines and benzodiazepines and consideration of whether benefits outweigh risks. Its scope is outpatient pain care for adults age 18 and older, excluding sickle cell disease-related pain, cancer-related pain, palliative care, and end-of-life care. It is not a uniform rule for stopping medication for opioid use disorder.[3]

Prescribed Together – Can You Take Opioids and Benzos Together?

Sometimes a clinician may determine that both are needed after reviewing individual benefits and risks. A prescription for each does not make the combination risk-free. For example, an existing benzodiazepine prescription needs to be considered when a new opioid pain medicine is proposed, even when each treats a valid problem.[2][3]

Ask what benefit requires each medicine, what alternatives are appropriate, how the prescribers will coordinate, and what changes in alertness or daily functioning should prompt contact. The answer may involve continuing, reducing, or changing treatment. It should not be assumed from a blanket rule about which medicine must stop first.[1][3]

Methadone, Suboxone and Benzodiazepines – Protecting Ongoing Treatment

Benzodiazepine use alone should not lead to withholding or suspending buprenorphine or methadone treatment for opioid use disorder. ASAM’s 2025 guideline and the CDC’s 2022 guidance explicitly protect access to these treatments while calling for management of the added risks. Co-use of methadone and benzodiazepines still needs coordinated medical attention.[1][3]

Buprenorphine can reduce opioid withdrawal and cravings and help people stay in treatment.[8] AddictionHelp.com’s buprenorphine overview explains that medication’s role. Preserving appropriate opioid use disorder treatment matters while the team addresses benzodiazepine-related risk. This does not mean every person should continue the exact same medicines or doses.[1][3]

Suboxone contains buprenorphine and naloxone and is used to treat opioid use disorder. Its December 2025 prescribing information warns that benzodiazepines and other central nervous system depressants increase respiratory depression, overdose, and death risk. It also says treatment should not be categorically denied because of their use, because barriers to treatment can create greater harm from untreated opioid use disorder.[6]

The naloxone ingredient in Suboxone does not cancel that interaction warning. Suboxone is not an emergency overdose-reversal product or a benzodiazepine antidote. If your list includes a benzo and methadone, or Suboxone and benzodiazepines, ask how the clinicians will address the interaction while maintaining access to appropriate opioid use disorder care. Do not change either medicine on your own.[1][4][6]

What to Do If You Take Both Right Now

Arrange a coordinated medication review before making changes on your own. The review should establish what each medicine is helping, how the combination affects you, and who is responsible for follow-up. A single shared list gives the prescribers and pharmacist something concrete to work from.[1][3]

  • What is each medicine helping now? Describe the treatment goal and current benefit, such as pain relief that allows daily activity, control of panic symptoms, or continued treatment for opioid use disorder. Ask how those needs will remain treated if the plan changes.[1][3]
  • Does everyone have the same complete list? Include prescriptions, over-the-counter medicines, sleep products, supplements, alcohol, and nonprescribed substances. Bring the containers or clear photographs of the labels if that makes the information easier to share.[1][4][3]
  • Who will coordinate any changes? Ask which prescriber will communicate with the other clinicians and pharmacist, who will explain the agreed plan, and whom you should contact if instructions conflict. For example, two different medication lists should be reconciled before you try to resolve the discrepancy yourself.[1][3]
  • Could changes in alertness or daily functioning be related? Describe specific changes, such as new daytime drowsiness or difficulty staying alert during ordinary tasks. Ask how to report these changes and what follow-up is appropriate. Trouble breathing or inability to awaken someone requires emergency help rather than a routine appointment.[1][2][5]
  • How will we prevent an interruption in care? Clarify refill arrangements, follow-up access, and whom to contact if a prescriber is unavailable. If a current medication gap or withdrawal symptoms are already a concern, seek prompt medical advice rather than improvising dose changes or restarting instructions.[1][4][3]
  • Can we arrange naloxone and a household emergency plan? Ask the pharmacist about obtaining naloxone and teaching household members how to use the available product. Decide where it will be kept and who knows that suspected overdose requires an immediate emergency call.[1][5]

If a Benzodiazepine Reduction Is Appropriate

A benzodiazepine reduction should be individualized and clinician-guided. Physical dependence can develop during prescribed use and is not automatically addiction. Once dependence is present, abrupt stopping or rapid reduction can cause severe withdrawal, including life-threatening seizures.[1][4]

A gradual plan lowers withdrawal risk but cannot eliminate significant symptoms or guarantee that complications will not occur. The goal may be a lower dose or discontinuation, depending on benefits, risks, and preferences. Some plans take months or longer, particularly after long-term use, and adjustments are part of responding to the person’s needs. There is no universal benzodiazepine-first or opioid-first sequence.[1][3]

Care should continue to address the condition the benzodiazepine was treating. For example, someone receiving treatment for panic symptoms needs an ongoing plan for panic, not only a medication reduction. ASAM recommends tailored behavioral support, such as cognitive behavioral therapy for anxiety or insomnia, although evidence that it improves benzodiazepine discontinuation is low certainty. Therapy supports care and does not replace medical prescribing or withdrawal assessment.[1]

Many people can receive benzodiazepine withdrawal care as outpatients. Severe withdrawal or unstable medical needs may require more intensive medical care, so taking both medicines does not automatically mean an inpatient stay. AddictionHelp.com’s guides to benzodiazepine tapering and benzodiazepine withdrawal explain the planning and support involved.[1]

Naloxone Limits – Does Narcan Work on Benzos?

No. Narcan is a brand of naloxone, which reverses opioid effects. It does not reverse benzodiazepines. If both drug classes are involved in an overdose, naloxone may help with the opioid component while leaving the benzodiazepine effects untreated.[5]

Call 911 immediately for suspected overdose, inability to awaken someone, or slow or absent breathing. If opioids may be involved, give available naloxone while help is coming. Never wait for a response before calling. Stay with the person until emergency help arrives, and do not treat improvement as proof that medical care is no longer needed.[5]

For preparation, ask a pharmacist to explain the naloxone product available to your household. Someone who knows where it is kept should also understand its limits and the need for emergency care. AddictionHelp.com’s Narcan overview provides background on opioid-overdose reversal.[1][5]

Getting Support Without Losing Needed Treatment

Start with a prescriber or pharmacist who can help coordinate medical care for the complete medication list. The goal is a workable plan that addresses the interaction while continuing to treat pain, anxiety, sleep problems, or opioid use disorder as appropriate. You do not have to decide alone which treatment should change.[1][3]

If you need a new care team, you can browse AddictionHelp.com’s treatment directory and ask facilities about medical prescribing, benzodiazepine withdrawal support, continuation of opioid use disorder medication, follow-up, availability, and payment. A directory listing does not establish that a particular facility offers the services you need, so confirm them directly.[1][3]

For emotional distress or suicidal thoughts in the United States, call 988 or text 988. This support has a different role from emergency medical care for an overdose, breathing problem, or seizure.[4][9][5]

Frequently Asked Questions

Why Is Mixing Benzodiazepines and Opioids So Dangerous?

Both can depress central nervous system activity, and benzodiazepines can increase opioid-related suppression of breathing. Together they can cause profound sedation, respiratory depression, coma, and overdose. The risk deserves attention even when both medicines were prescribed for valid reasons.[2][3]

If both are depressants, are benzodiazepines opioids? No. They are different drug classes whose effects can overlap. Have the complete combination reviewed by the prescribers and pharmacist rather than assuming that different treatment purposes prevent an interaction.[1][2][3]

Does Naloxone (Narcan) Reverse a Benzodiazepine Overdose?

No. Naloxone reverses opioid effects, not benzodiazepine effects. In an overdose involving both, it may help with the opioid component without reversing the benzodiazepine component.[5]

Call 911 immediately if someone may be overdosing, cannot be awakened, or has slow or absent breathing. If opioids may be involved, give available naloxone while emergency help is coming. Do not wait for it to work before calling. Stay with the person until help arrives, even if they improve.[5]

What Is the FDA Boxed Warning About Opioids and Benzodiazepines?

The FDA’s 2016 boxed-warning action addressed the serious risks of combining prescription opioid pain or cough medicines with benzodiazepines, including extreme sleepiness, respiratory depression, coma, and death. Its 2020 benzodiazepine warning update also addressed abuse, misuse, addiction, physical dependence, and withdrawal.[2][4]

The warnings call for careful medication decisions, not abrupt self-discontinuation. Current CDC guidance for adult outpatient pain care calls for particular caution and an individualized benefit–risk review. Buprenorphine or methadone treatment for opioid use disorder should not be withheld solely because of benzodiazepine use.[1][3]

How Do People End Up Taking Both Opioids and Benzodiazepines?

People may have overlapping conditions, such as pain and anxiety, or receive treatment from different prescribers. For example, an opioid pain prescription may be added while someone is already taking a benzodiazepine. Other people may use one or both without a prescription, which also deserves medical assessment without blame.[1][2][3]

Bring one complete list of medicines and substances to each prescriber and the pharmacist, and ask who will coordinate the plan. Taking both does not by itself diagnose addiction, and physical dependence can develop during prescribed benzodiazepine use.[1][4]

If I Take Both, How Do I Come Off Safely?

Begin with a coordinated review of whether either medicine should change. Not everyone needs to stop both, and there is no universal rule about which medicine should be reduced first. Do not abruptly stop a regularly used benzodiazepine, because withdrawal can include life-threatening seizures.[1][4][3]

If a benzodiazepine reduction is appropriate, an individualized gradual plan can lower withdrawal risk but cannot guarantee freedom from symptoms or complications. The plan should include follow-up and care for the condition being treated. Benzodiazepine use alone is not a reason to withhold or suspend buprenorphine or methadone treatment for opioid use disorder.[1][3]

Who Is Most at Risk from Combining Opioids and Benzodiazepines?

Everyone taking the combination needs an individualized review. CDC guidance identifies greater concern with unpredictable use, higher concurrent dosages, and alcohol or other central nervous system depressants. Stable prescribed use or a lower dose does not establish zero risk. These factors cannot reliably rank an individual’s risk without clinical assessment.[3]

Share the exact medicines, other substances, health concerns, and changes in alertness or daily functioning with the prescribers and pharmacist. Ask about naloxone access and a household emergency plan. Someone who cannot be awakened or has slow or absent breathing needs an immediate call to 911, not a routine medication review.[1][5][3]

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

9 Sources
  1. American Society of Addiction Medicine. (2025). Joint clinical practice guideline on benzodiazepine tapering: Considerations when benzodiazepine risks outweigh benefits. https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/benzodiazepine-tapering-2025/bzd-tapering-document---final-approved-version-for-distribution-02-28-25.pdf Read source 1
  2. U.S. Food and Drug Administration. (2016, August 31). New safety measures announced for opioid analgesics, prescription opioid cough products, and benzodiazepines. https://www.fda.gov/drugs/food-and-drug-administration-overdose-prevention-framework/new-safety-measures-announced-opioid-analgesics-prescription-opioid-cough-products-and Read source 2
  3. Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recommendations and Reports, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1 Read source 3
  4. U.S. Food and Drug Administration. (2020, September 23). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class. https://www.fda.gov/drugs/drug-safety-and-availability/fda-requiring-boxed-warning-updated-improve-safe-use-benzodiazepine-drug-class Read source 4
  5. Centers for Disease Control and Prevention. (2024, May 2). 5 things to know about naloxone. https://www.cdc.gov/overdose-prevention/reversing-overdose/about-naloxone.html Read source 5
  6. Indivior Inc. (2025, December). Suboxone (buprenorphine and naloxone) sublingual film [Prescribing information, revised December 2025]. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/022410s057lbl.pdf Read source 6
  7. Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017). Association between concurrent use of prescription opioids and benzodiazepines and overdose: Retrospective analysis. BMJ, 356, j760. https://doi.org/10.1136/bmj.j760 Read source 7
  8. National Institute on Drug Abuse. (2025, March 20). Medications for opioid use disorder. https://nida.nih.gov/research-topics/medications-opioid-use-disorder Read source 8
  9. 988 Suicide & Crisis Lifeline. (n.d.). 988 Suicide & Crisis Lifeline. https://988lifeline.org?oai_link_source=model_response_hotline Read source 9
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.